TITLE

P618 PAR2 expression differentially regulates immune response upon treatment with Poly(I:C) and LPS

AUTHOR(S)
Weithaeuser, A; Schultheiss, HP; Rauch, U
PUB. DATE
July 2014
SOURCE
Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS112
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: The protease activated receptor 2 (PAR2) is a G-protein coupled receptor, that is activated by serine proteases such as trypsin, tryptase and the complex composed of tissue factor (TF)/ factor VII (FVII) and factor X (FX). PAR2 is also involved in modulating immune response after infections with pathogens. The activation of PAR2 is associated with the induction of a pro-inflammatory response by induction of gene expression of cytokines, such as IL8. Here we studied role of PAR2 for the innate immune response in the heart.Methods: Biopsies of patients suffering from cardiomyopathy and mouse hearts of wt and PAR2ko mice were examined for IFNβ, TNFα and IL6 mRNA expression with real time PCR. Fibroblasts were isolated from wildtype (wt) and PAR2 knockout (ko) mouse hearts and stimulated with poly(I:C) and LPS for different time points. IFNβ, IL6 and TNFα mRNA expression was determined with real time PCR. For IFNβ pathway analysis western blot and co-immunoprecipitation was performed.Results: The stimulation with poly(I:C) led to an increased expression of antiviral IFNβ and CCL5 in PAR2ko fibroblasts compared to wt fibroblasts (n=3-5, p<0.05 wt vs PAR2ko). Furthermore, the transcription factors NFκB and Stat1 were stronger activated in PAR2ko cells. Poly(I:C) activates TLR3 and co-immunoprecipitations revealed that the negative regulation of IFNβ expression by PAR2 was dependent on a physical interaction between PAR2 and TLR3. When stimulating TLR4 with LPS the pro-inflammatory cytokine IL6 was stronger up-regulated in PAR2ko fibroblasts than in wt fibroblasts (n=3, p<0.05). Contrarily, the gene expression of TNFα was lower in PAR2ko fibroblasts than in wt fibroblasts (n=3-5, p<0.05). Thus, the stimulation of TLR3 and TLR4 led to opposite immune responses dependent on the presence of PAR2 in the fibroblasts.In human hearts a low PAR2 expression was associated with a low expression of the pro-inflammatory cytokines TNFα and IL6 and vice versa (n=100, p<0.05). Further, a low PAR2 expression was associated with a high IFNβ expression in the heart (n=100, p<0.05). These data point to PAR2 to regulate innate immune responses in the heart.Conclusion: The lack of PAR2 leads to an enhanced antiviral immune response after stimulation of TLR3 with poly(I:C). In contrast, PAR2 deficiency evokes a pro-inflammatory response after stimulation of TLR4 with LPS. Thus, dependent on the pathogen PAR2 functions as a pro- or an anti-inflammatory mediator of the immune system.
ACCESSION #
96949654

 

Related Articles

  • Increased Expression of Protease-Activated Receptor 4 and Trefoil Factor 2 in Human Colorectal Cancer. Yu, Guoyu; Jiang, Ping; Xiang, Yang; Zhang, Yong; Zhu, Zhu; Zhang, Chuanrao; Lee, Siman; Lee, Wenhui; Zhang, Yun // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Protease-activated receptor 4 (PAR4), a member of G-protein coupled receptors family, was recently reported to exhibit decreased expression in gastric cancer and esophageal squamous cancer, yet increased expression during the progression of prostate cancer. Trefoil factor 2 (TFF2), a small...

  • The Expression of the Thrombin Receptors PAR-3 and PAR-4 is Downregulated in Pancreatic Cancer Cell Lines. Rudroff, Claudia; Richard, Annette; Hilswicht, Sarah; Neugebauer, Edmund A. M. // Jurnalul de Chirurgie;2014, Vol. 10 Issue 1, p31 

    Background: Patients with pancreatic cancer frequently suffer from thrombosis as a consequence of excess thrombin generation. In addition to its role in the plasmatic coagulation cascade, thrombin induces numerous cellular effects by activating a unique group of G-protein-coupled receptors on...

  • The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Gatto, Dominique; Wood, Katherine; Caminschi, Irina; Murphy-Durland, Danielle; Schofield, Peter; Christ, Daniel; Karupiah, Gunasegaran; Brink, Robert // Nature Immunology;May2013, Vol. 14 Issue 5, p446 

    Spleen-resident dendritic cell (DC) populations occupy sentinel positions for the capture and presentation of blood-borne antigens. Here we found a difference in expression of the chemotactic receptor EBI2 (GPR183) on splenic DC subsets and that EBI2 regulated the positioning and homeostasis of...

  • Breaking barriers: a GPCR triggers immunity in nematodes. Luallen, Robert J; Troemel, Emily R // Nature Immunology;Sep2014, Vol. 15 Issue 9, p826 

    No abstract available.

  • Human Macrophage Response to L. (Viannia) panamensis: Microarray Evidence for an Early Inflammatory Response. Ramírez, Carolina; Díaz-Toro, Yira; Tellez, Jair; Castilho, Tiago M.; Rojas, Ricardo; Ettinger, Nicholas A.; Tikhonova, Irina; Alexander, Neal D.; Valderrama, Liliana; Hager, Janet; Wilson, Mary E.; Aiping Lin; Hongyu Zhao; Saravia, Nancy G.; McMahon-Pratt, Diane // PLoS Neglected Tropical Diseases;Oct2012, Vol. 6 Issue 10, p1 

    Background: Previous findings indicate that susceptibility to Leishmania (Viannia) panamensis infection of monocytederived macrophages from patients and asymptomatically infected individuals were associated with the adaptive immune response and clinical outcome. Methodology/Principal Findings:...

  • PERSPECTIVE. Coughlin, Shaun // Cardiology Today;Jun2014, Vol. 17 Issue 6, p30 

    The author discusses the health benefits of protease activated receptor-1 (PAR-1).

  • Targeting A549 lung adenocarcinoma cell growth and invasion with protease-activated receptor-1 siRNA. ZHUO WU; YANYAN ZENG; MINGKANG ZHONG; BIN WANG // Molecular Medicine Reports;2014, Vol. 9 Issue 5, p1787 

    Lung cancer is the major cause of cancer-associated mortality worldwide and the invasive and metastatic characteristics of lung tumor cells are responsible for their high malignancy. Protease-activated receptor 1 (PARI) is a G-protein-coupled receptor (GPCR) which is activated by a unique...

  • Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death. Burns, Kelly E.; Thèvenin, Damien // Biochemical Journal;12/15/2015, Vol. 472 Issue 3, p287 

    Even though abnormal expression of G protein-coupled receptors (GPCRs) and of their ligands is observed in many cancer cells of various origins, only a few anti-cancer compounds directly act on their signalling. One promising approach to modulate their activity consists of targeting the receptor...

  • Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist. Cho, Nam-Chul; Seo, Seoung-Hwan; Kim, Dohee; Shin, Ji-Sun; Ju, Jeongmin; Seong, Jihye; Seo, Seon; Lee, Iiyoun; Lee, Kyung-Tae; Kim, Yun; No, Kyoung; Pae, Ae // Journal of Computer-Aided Molecular Design;Aug2016, Vol. 30 Issue 8, p625 

    Protease-activated receptor 2 (PAR) is a G protein-coupled receptor, mediating inflammation and pain signaling in neurons, thus it is considered to be a potential therapeutic target for inflammatory diseases. In this study, we performed a ligand-based virtual screening of 1.6 million compounds...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics